HIV early infant diagnosis and viral load point of care diagnostics: market and supply update
A market and supply updated on point-of-care (POC) tests for HIV early infant diagnosis (EID) and viral load (VL) testing
UNICEF procures and supplies point-of-care (POC) tests for HIV early infant diagnosis (EID) and viral load (VL) testing, focusing its support on pregnant women, mothers, infants, children, and adolescents.
This note provides market and supply information on these products. UNICEF’s procurement of POC tests for HIV EID and VL testing has grown substantially since 2015 to reach 445,342 tests by 2019, of which approximately sixty per cent were for HIV EID POC tests.
Currently only 51 per cent of all HIV-exposed infants are tested for HIV. UNICEF encourages manufacturers to increase affordability to facilitate growth in demand and support countries to scale up their use of innovative POC technologies for HIV EID and VL testing.